Discovery of small molecule human FPR1 receptor antagonists
- 15 May 2011
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (10), 2991-2997
- https://doi.org/10.1016/j.bmcl.2011.03.049
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) FamilyPharmacological Reviews, 2009
- Duplex high‐throughput flow cytometry screen identifies two novel formylpeptide receptor family probesCytometry Part A, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in VivoDrug Metabolism and Disposition, 2007
- Integration of Virtual Screening with High-Throughput Flow Cytometry to Identify Novel Small Molecule Formylpeptide Receptor AntagonistsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2005
- High-Throughput Screening with HyperCyt® Flow Cytometry to Detect Small Molecule Formylpeptide Receptor LigandsSLAS Discovery, 2005
- Cyclosporins: Structure−Activity Relationships for the Inhibition of the Human FPR1 Formylpeptide ReceptorJournal of Medicinal Chemistry, 2002
- Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay TechnologySLAS Discovery, 1999
- FLIPR: A New Instrument for Accurate, High Throughput Optical ScreeningSLAS Discovery, 1996
- N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation.The Journal of Experimental Medicine, 1995